Ascendis Pharma A/S (Nasdaq: ASND) today announced new data from Week 214 of its Phase 2 PaTH Forward Trial showing that long ...

CAMBRIDGE, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company ...

"Life360 started 2025 strongly, achieving record highs in MAUs, subscribers, and Q1 net additions, while making meaningful ...

ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA, or "ZyVersa”), a clinical-stage specialty biopharmaceutical company developing ...

NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- ODDITY Tech Ltd. (the "Company”) (NASDAQ: ODD) today announced the sale of ...

Further to the news release of the Company dated May 1, 2025, with this exercise of warrants by the Or family, Beyond Oil has ...

Consolidated revenues for Q1 2025 rose 29% to $6.4 million from $5.0 million in Q1 2024, driven by a 92% increase in FUEL ...

Upon suspension of the trading of its Common Stock on Nasdaq, the Company expects that its Common Stock will be quoted under ...

Atea defines working capital as current assets less current liabilities. See the Company's condensed consolidated financial ...

FORT WORTH, Texas, May 12, 2025 (GLOBE NEWSWIRE) -- Tandy Leather Factory, Inc. (Nasdaq: TLF) today announced the Company's ...

On May 5, 2025, the Company completed a permitted voluntary loan to bond exchange for its $580 million of USD fixed rate ...

"We are very pleased to welcome Dr. Chittipeddi to the Lantronix Board of Directors,” said Hoshi Printer, chairman of the ...